Meetings - The ASCO Post

/ Navigating the T-Cell Therapy Landscape in Multiple Myeloma

Case 3: Optimal Sequencing of T-Cell–Redirected Therapies

This is Part 3 of Personalizing Therapy for Patients With Glioma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Kenneth Anders...

/ Navigating the T-Cell Therapy Landscape in Multiple Myeloma

Case 2: Role of T-Cell–Redirected Therapies in Elderly Patients With Relapsed/Refractory Multiple Myeloma

This is Part 2 of Personalizing Therapy for Patients With Glioma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Kenneth Anders...

/ Navigating the T-Cell Therapy Landscape in Multiple Myeloma

Case 1: Role of ASCT in the Era of Quadruplet Induction and T-Cell–Redirected Therapies

This is Part 1 of Navigating the T-Cell Therapy Landscape in Multiple Myeloma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. ...

Navigating the T-Cell Therapy Landscape in Multiple Myeloma

Case 3: Optimal Sequencing of T-Cell–Redirected Therapies

Case 2: Role of T-Cell–Redirected Therapies in Elderly Patients With Relapsed/Refractory Multiple Myeloma

Case 1: Role of ASCT in the Era of Quadruplet Induction and T-Cell–Redirected Therapies

Kinase Inhibitor Approved for Nonsquamous NSCLC With HER2 TKD–Activating Mutations

Potential New Second-Line Standard of Care Emerges in Small Cell Lung Cancer

Mortality in Advanced-Stage Ovarian Cancer—Effect of Neoadjuvant Chemotherapy and Cytoreductive Surgery Case Volume

Smoking Cessation in Cancer Care: Challenges and Opportunities

GLP-1 Receptor Agonists vs Other Glucose-Lowering Drugs: Survival in Older Patients With Cancer and Diabetes